Acceleron Pharma
XLRN
#1890
Rank
ยฃ8.28 B
Marketcap
ยฃ135.41
Share price
0.00%
Change (1 day)
15,011.00%
Change (1 year)

Earnings for Acceleron Pharma (XLRN)

Earnings in 2021 (TTM): -ยฃ0.19 Billion

According to Acceleron Pharma's latest financial reports the company's current earnings are ยฃ0.11 Billion. In 2020 the company made an earning of -ยฃ0.13 Billion a decrease over its 2019 earnings that were of -ยฃ0.11 Billion.

Earnings history for Acceleron Pharma from 2012 to 2021

Annual earnings

Year Earnings Change
2021 (TTM)-ยฃ0.19 Billion47.43%
2020-ยฃ0.13 Billion22.62%
2019-ยฃ0.11 Billion9.67%
2018-ยฃ94.25 Million13.12%
2017-ยฃ83.32 Million92.99%
2016-ยฃ43.18 Million-6.39%
2015-ยฃ46.13 Million20.95%
2014-ยฃ38.14 Million154.15%
2013-ยฃ15.01 Million-36.22%
2012-ยฃ23.53 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
ยฃ14.18 B-7,427.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ5.27 B-2,827.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ8.37 B-4,425.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
ยฃ4.30 B-2,325.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-ยฃ83.58 Million-56.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-ยฃ13.76 Million-92.89%๐Ÿ‡บ๐Ÿ‡ธ USA
bluebird bio
BLUE
-ยฃ0.16 Billion-21.79%๐Ÿ‡บ๐Ÿ‡ธ USA